Document is current
Any future updates will be listed below
-
Authors
Bulthuis, Nicholas E. https://orcid.org/0000-0002-2367-7992
Quintana, Liliette I. https://orcid.org/0000-0003-1480-095X
Stackmann, Michelle
Denny, Christine A. https://orcid.org/0000-0002-6926-2020
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD101402, T32 HD007430)
New York State Psychiatric Institute
National Science Foundation (DGE 2036197)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (F31 AG090071)
Barnard Summer Research Institute
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (F99 NS129178)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (F31 MH125656)
- License Information
-
More Information
Article History
Received: 5 September 2024
Accepted: 5 September 2025
First Online: 9 October 2025
Competing interests
: N.B., L.Q. and M.S. declare no competing interests. C.A.D. is named on provisional, non-provisional, and awarded patent applications for the prophylactic use of (R, S)-ketamine and related compounds against stress-related psychiatric disorders; however, these patents are not applicable to this study, and C.A.D. therefore declares no competing interests.
